Press "Enter" to skip to content

New patent expiration for Gilead Sciences drug GENVOYA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Gilead Sciences drug GENVOYA

Annual Drug Patent Expirations for GENVOYA
Annual Drug Patent Expirations for GENVOYA

Genvoya is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting this drug.

Drug patent litigation for GENVOYA.

This drug has four hundred and forty-one patent family members in fifty-four countries.

The generic ingredient in GENVOYA is cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. Two suppliers are listed for this compound. Additional details are available on the cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Gilead Sciences drug GENVOYA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions